What happened during this study?
The participants were in the study for as long as the study doctors thought the
treatment was helping them. But the entire study took nearly 3 years to finish.
The study started in April 2017 and ended in March 2020. Participants benefitting
from the study treatment continued to receive durvalumab in an extension phase
of the study, which is ongoing.
6 | Clinical Study Results